Learn entry

Coeliac Disease Pathophysiology: From Gliadin to Villous Atrophy

Coeliac disease is a masterclass in autoimmunity — one protein, one enzyme, one HLA molecule, and a cascade that destroys the intestinal lining.

Understand11 min read Editor's pick
How this entry is structured
Definitions first, then mechanisms, then “so what?”. If you are in a hurry, skim the headings and callouts.
Not medical advice
Educational content only. If symptoms are severe, persistent, or worrying, see a clinician.

The Perfect Immunological Storm

Coeliac disease requires three converging elements: dietary gluten (specifically gliadin peptides from wheat, and homologous prolamins from barley and rye), the HLA-DQ2 or HLA-DQ8 genotype (present in nearly all coeliac patients, but also 30 to 40 percent of the general population), and environmental triggers that breach tolerance. The result is a T cell-mediated adaptive immune response that is unique among autoimmune diseases in having an identified exogenous trigger.

Gliadin's Unusual Resistance to Digestion

Gluten proteins are unusually rich in proline and glutamine residues, which resist cleavage by gastric, pancreatic, and brush border peptidases. The resulting large peptide fragments — particularly a 33-amino-acid fragment from alpha-gliadin — survive transit to the small intestinal lamina propria intact, retaining their immunogenic potential.

The tTG Amplifier

In the lamina propria, the enzyme tissue transglutaminase (tTG) deamidates specific glutamine residues on gliadin peptides, converting them to negatively charged glutamic acid. This deamidation dramatically increases the binding affinity of these peptides for the HLA-DQ2 or DQ8 groove on antigen-presenting cells. The modified peptides are now potent activators of CD4+ T helper cells, which mount a Th1-dominant immune response with production of IFN-gamma, TNF-alpha, and IL-21.

Simultaneously, tTG-gliadin complexes stimulate B cells to produce antibodies — anti-tTG (the basis of the serological screening test), anti-endomysial antibodies, and anti-deamidated gliadin peptide antibodies. The autoantibody against tTG itself is a hallmark that makes coeliac disease a true autoimmune condition with an identified autoantigen.

The Destructive Cascade

The CD4+ T cell response drives two parallel destructive pathways. Cytokines activate lamina propria fibroblasts and matrix metalloproteinases that remodel the extracellular matrix, causing crypt hyperplasia. Meanwhile, IL-15 — produced by stressed epithelial cells — activates intraepithelial lymphocytes (IELs) expressing NKG2D receptors, which directly kill enterocytes bearing the stress ligand MICA. This cytotoxic IEL pathway is partly independent of the adaptive immune response and is particularly important in refractory coeliac disease.

The net result is progressive villous atrophy: the finger-like villi that maximise absorptive surface area flatten, crypts elongate to compensate, and IELs infiltrate the epithelium — the histological triad captured by the Marsh-Oberhuber classification.

Permeability and Zonulin

Gliadin also activates the zonulin pathway through the CXCR3 receptor on enterocytes, triggering phosphorylation and disassembly of tight junction proteins (ZO-1, occludin). The resulting increase in paracellular permeability allows more gliadin peptides to reach the lamina propria, creating a feed-forward loop. This zonulin-mediated barrier disruption is one of the earlier events in disease pathogenesis and may precede full villous atrophy.

The entire cascade is reversible: strict gluten avoidance removes the antigenic stimulus, inflammation subsides, tight junctions reassemble, and villi regenerate — typically within 6 to 24 months, though some patients require longer.

Was this entry helpful?

Sources & references

  1. Sollid LM et al. (2023) Celiac disease: immunopathogenesis update J Clin Invest PMID: 37234890
  2. Wahab PJ et al. (2002) Coeliac disease: more than villous atrophy Gut PMID: 12145668
  3. Reshetnyak VI et al. (2021) Helicobacter pylori: Commensal, symbiont or pathogen? World Journal of Gastroenterology PMID: 33642828
  4. Elghannam MT et al. (2023) Helicobacter pylori and oral-gut microbiome: clinical implications Infection PMID: 37917397
  5. Magro F et al. (2017) Microscopic colitis: A literature review Revista da Associação Médica Brasileira PMID: 28001266
Editorial standards
Every entry is grounded in peer-reviewed research and reviewed for accuracy. How we write →